The FTSE 100 continued making gains on Friday, reaching levels last seen before Donald Trump announced sweeping global trade tariffs in early April. London’s blue-chip index ended the day up 46.01 points to finish at 8,679.76, a 0.53% increase. Mr Trump said on Friday that the US is to set new tariff rates, after several weeks spent scaling back sweeping import levies on goods imported into the US. The US president said it was “not possible to meet the number of people that want to see us” to make a trade deal. It comes after the US struck a deal with the UK earlier this month, providing relief on tariffs for products including steel and cars. The country also jointly announced tariff reductions with China this week. Michael Hewson, an analyst at MCH Insights, said markets appeared to have decided that the tariff threat was over, at least temporarily. He said the market “appears to have made up its mind” over tariffs, pointing to record highs on Germany’s Dax index and more gains on the FTSE 100. “It’s notable that the best gainers year to date are the likes of Babcock, BAE Systems and Rolls-Royce, all companies that do a significant amount of business in the US,” he said. In Europe, Germany’s Dax rose 0.075%, after earlier gains were tempered later in the day, and France’s Cac 40 rose 0.19%. On Wall Street, the S&P 500 was up 0.054% as UK markets were closing, while the Dow Jones was up 0.012%. Sterling was down 0.33% against the US dollar at 1.3261, while it was 0.081% up against the euro at 1.1897. In company news, media and comparison website group Future said it expects revenues to decline this financial year in the face of “ongoing macroeconomic uncertainty”. The Go.Compare and Marie Claire owner said it is adopting a “more cautious view” for the second half of the year in the face of “challenging” market conditions. The group said its US direct digital advertising business witnessed a “weaker performance” in March, but returned to growth last month. Shares in the company plunged 9.37%. Elsewhere, the bidding war for NHS landlord Assura looked to be heating up after healthcare investor Primary Health Properties (PHP) said it had made an offer worth £1.68 billion. It outbids the £1.61 billion takeover price offered by US private equity giants Kohlberg Kravis Roberts (KKR) and Stonepeak Partners, which Assura said it had accepted last month. The takeover tussle for the medical property giant has seen both bidders up their offers several times to try and clinch a deal. Story Continues Assura shares rose 1.6%. The biggest risers on the FTSE 100 were British American Tobacco, up 110p to 3187p, GSK, up 32p to 1394.5p, St James’s Place, up 23p to 1094p, Scottish Mortgage Investment Trust, up 19.3p to 1010.5p, and F&C Investment Trust, up 21p to 1110p. The biggest fallers on the FTSE 100 were Anglo American, down 77p to 2066p, Melrose Industries, down 10.2p to 465.4p, Antofagasta, down 35p to 1821p, Glencore, down 4.6p to 266p, and Kingfisher, down 5.3p to 310.8p. View Comments
FTSE 100 recovers to pre-trade tariff announcement levels
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...